Power to the Patients cover art

Power to the Patients

Power to the Patients

Written by: Brandon Li
Listen for free

About this listen

 Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation. Looking for a clinical trial? Visit us at www.withpower.com315762 Biological Sciences Science
Episodes
  • Turning Pain Into Progress: How Sonia Prashar Built a Mission Around Mental Health

    Turning Pain Into Progress: How Sonia Prashar Built a Mission Around Mental Health
    Feb 18 2026
    In this episode of Power to the Patients, Brandon Li and Sonia Prashar, Founder and CEO of AIM Trials, sit down to discuss how hybrid and decentralized clinical trial models are reshaping mental health research. Sonia shares how her personal experience with postpartum depression inspired a mission to reduce patient burden, expand access, and improve data quality, while challenging stigma and outdated research assumptions along the way.
    Show More Show Less
    34 mins
  • The Synapse Secret: How One Molecule Normalized Brain Activity in Fragile X Patients

    The Synapse Secret: How One Molecule Normalized Brain Activity in Fragile X Patients
    Feb 11 2026
    In this episode of Power to the Patients, Brandon Li sits down with Dr. Craig Erickson, Research Director and Research Endowed Professor at Cincinnati Children’s, to explore how synaptic restoration is revolutionizing treatment for Fragile X, autism, ALS, Alzheimer's, and schizophrenia. From his decades of clinical experience and pioneering work at Spinogenix, Dr. Erickson shares the science behind restoring brain connectivity, the bold early results that surprised even experts, and why this approach could transform outcomes for patients with devastating neurological disorders.
    Show More Show Less
    39 mins
  • Beyond Dopamine: Why Traditional Schizophrenia Treatments Miss 50% of Patient Needs

    Beyond Dopamine: Why Traditional Schizophrenia Treatments Miss 50% of Patient Needs
    Feb 4 2026
    In this episode of Power to the Patients, Brandon Li sits down with Dr. Laxminarayan Bhat, Founder and CEO of Reviva Pharmaceuticals, to explore groundbreaking developments in schizophrenia treatment. Dr. Bhat shares insights on his company's innovative drug that shows promising results with fewer side effects and better patient adherence than existing treatments. Discover how their unique approach to targeting serotonin-dopamine signaling, combined with reduced off-target effects, could transform the lives of millions living with schizophrenia. Learn about the challenges and triumphs of developing psychiatric medications, the role of biomarkers in treatment, and the future of precision psychiatry.
    Show More Show Less
    32 mins
No reviews yet